Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

NCT00027976 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Precancerous Condition

Interventions

DRUG: celecoxib
DRUG: Placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]